Exact Sciences Completes Combination With Genomic Health Creating Leading Global Cancer Diagnostics Company | Latest News RSS feed

Exact Sciences Completes Combination With Genomic Health Creating Leading Global Cancer Diagnostics Company - Latest News


Exact Sciences Completes Combination with Genomic Health, Creating Leading Global Cancer Diagnostics Company

Combined company joins two leading brands in cancer diagnostics, Cologuard® and Oncotype DX®, providing a strong platform for continued growth MADISON, Wis. , Nov. 8, 2019 /CNW/ -- Exact Sciences Corp ... read more

Add your link right here

Add your story here to improve SEO, search ranking and drive traffic to your website. Your link will be permanently featured right on this page. To add a link on diferent page, just visit the page you want to show your link and click "Add your link right here". You can use search form below to find the page. read more

Exact Sciences Buying Genomic Health in $2.8B Cancer Diagnostics Deal

The result is a deal announced Monday to acquire Genomic Health for $2.8 billion in cash and stock, a combination that Exact CEO Kevin Conroy argues will create a global leader ... to create a leading ... read more

Exact Sciences Merging With Genomic Health: Details About The $2.8 Billion Deal

As a combined company, Exact Sciences and Genomic Health will create a leading global cancer diagnostics company ... And additionally, the combination is expected to generate annualized cost synergies ... read more

Looking for another news?


Exact Sciences to buy company with diagnostic test for breast cancer for $2.8 billion

They expect to complete the transaction by the ... “Combining industry pioneers Exact Sciences and Genomic Health is a pivotal step toward building the leading cancer diagnostics company in the world, ... read more


Exact Sciences, Genomic deal will yield greater cancer diagnostic R&D in $20B market

this combination is about bringing together complementary capabilities to create a leading cancer diagnostics company with unique abilities to impact more people’s lives." As of the end March, Genomic ... read more

Exact Sciences (EXAS) to Post Q3 Earnings: What's in Store?

Meanwhile, in July 2019, Exact Sciences announced that it will acquire Genomic Health, Inc. GHDX for $2.8 billion to create a leading global cancer diagnostics ... The company is scheduled to release ... read more

Exact Sciences Gets FDA Nod for Label Expansion of Cologuard

In July, Exact Sciences announced that it will acquire Genomic Health, Inc. GHDX for $2.8 billion, thereby creating a leading global cancer diagnostics company. The combined ... You can see the ... read more

Exact Sciences and Genomic Health to Combine, Creating Leading Global Cancer Diagnostics Company

Together, Exact Sciences and Genomic Health will create a leading global cancer diagnostics company. The combined company will offer two of the strongest and fastest growing brands in cancer ... read more

Exact Sciences and Genomic Health to Combine, Creating Leading Global Cancer Diagnostics Company

Together, Exact Sciences and Genomic Health will create a leading global cancer diagnostics ... company expects to generate revenue of approximately $1.6 billion and gross profit of approximately $1.2 ... read more

Exact Sciences and Genomic Health to Combine, Creating Leading Global Cancer Diagnostics Company

MADISON, Wis. and REDWOOD CITY, Calif., July 29, 2019 /PRNewswire/ -- Exact Sciences Corp. (NASDAQ:EXAS) and Genomic Health, Inc. (NASDAQ:GHDX) today announced that the companies have entered into a ... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us